1. A chronic animal model of migraine, induced by repeated meningeal nociception, characterized by a behavioral and pharmacological approach. (October 2013) Authors: Melo-Carrillo, Agustin; Lopez-Avila, Alberto Journal: Cephalalgia Issue: Volume 33:Number 13(2013) Page Start: 1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD. (August 2022) Authors: Strassman, Andrew M; Melo-Carrillo, Agustin; Houle, Timothy T; Adams, Aubrey; Brin, Mitchell F; Burstein, Rami Journal: Cephalalgia Issue: Volume 42:Number 9(2022) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Celecoxib reduces cortical spreading depression–induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in terminating migraine attacks. Issue 5 (May 2020) Authors: Schain, Aaron J.; Melo-Carrillo, Agustin; Ashina, Sait; Strassman, Andrew M.; Burstein, Rami Journal: Pain Issue: Volume 161:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons. (January 2021) Authors: Melo-Carrillo, Agustin; Strassman, Andrew M; Schain, Aaron J; Adams, Aubrey Manack; Brin, Mitchell F; Burstein, Rami Journal: Cephalalgia Issue: Volume 41:Number 1(2021) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats. (October 2019) Authors: Melo-Carrillo, Agustin; Strassman, Andrew M; Schain, Aaron J; Noseda, Rodrigo; Ashina, Sait; Adams, Aubrey; Brin, Mitchell F; Burstein, Rami Journal: Cephalalgia Issue: Volume 39:Number 11(2019) Page Start: 1358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. (March 2020) Authors: Noseda, Rodrigo; Schain, Aaron J; Melo-Carrillo, Agustin; Tien, Jason; Stratton, Jennifer; Mai, Fanny; Strassman, Andrew M; Burstein, Rami Journal: Cephalalgia Issue: Volume 40:Number 3(2020) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood–brain barrier. Issue 5 (May 2020) Authors: Melo-Carrillo, Agustin; Schain, Aaron J.; Stratton, Jennifer; Strassman, Andrew M.; Burstein, Rami Journal: Pain Issue: Volume 161:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Migraine and the trigeminovascular system—40 years and counting. Issue 8 (August 2019) Authors: Ashina, Messoud; Hansen, Jakob Møller; Do, Thien Phu; Melo-Carrillo, Agustin; Burstein, Rami; Moskowitz, Michael A Journal: Lancet neurology Issue: Volume 18:Issue 8(2019) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier. Issue 9 (September 2021) Authors: Melo-Carrillo, Agustin; Strassman, Andrew M.; Schain, Aaron J.; Broide, Ron S.; Cai, Brian B.; Rhéaume, Catherine; Brideau-Andersen, Amy D.; Ashina, Sait; Flores-Montanez, Yadira; Brin, Mitchell F.; Burstein, Rami Journal: Pain Issue: Volume 162:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: A prospective quantitative sensory testing study (NCT04271202). (March 2023) Authors: Ashina, Sait; Melo-Carrillo, Agustin; Szabo, Edina; Borsook, David; Burstein, Rami Journal: Cephalalgia Issue: Volume 43:Number 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗